Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

B cells mediate chronic allograft rejection independently of antibody production.

Zeng Q, Ng YH, Singh T, Jiang K, Sheriff KA, Ippolito R, Zahalka S, Li Q, Randhawa P, Hoffman RA, Ramaswami B, Lund FE, Chalasani G.

J Clin Invest. 2014 Mar;124(3):1052-6. doi: 10.1172/JCI70084. Epub 2014 Feb 10.

2.

Natural killer cells play a critical role in cardiac allograft vasculopathy in an interleukin-6--dependent manner.

Zhang ZX, Huang X, Jiang J, Lian D, Min WP, Liu W, Haig A, Jevnikar AM.

Transplantation. 2014 Nov 27;98(10):1029-39. doi: 10.1097/TP.0000000000000405.

PMID:
25286056
3.

B cells assist allograft rejection in the deficiency of protein kinase c-theta.

Yan W, Xu R, Ma LL, Han W, Geevarghese SK, Williams PE, Sciammas R, Chong AS, Yin DP.

Transpl Int. 2013 Sep;26(9):919-27. doi: 10.1111/tri.12143. Epub 2013 Jul 11.

4.

Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.

Iida S, Omoto K, Kanemitsu I, Setoguchi K, Ishida H, Tanabe K, Suzuki T, Tashiro Y, Kishimoto H, Abe R.

Exp Clin Transplant. 2012 Aug;10(4):375-85. doi: 10.6002/ect.2011.0159. Epub 2012 Jul 2.

5.

Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology.

Zecher D, Li Q, Williams AL, Walters JT, Baddoura FK, Chalasani G, Rothstein DM, Shlomchik WD, Demetris AJ, Lakkis FG.

Transpl Immunol. 2012 Mar;26(2-3):113-8. doi: 10.1016/j.trim.2011.12.006. Epub 2011 Dec 24.

6.

Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes.

Yoshimura R, Chargui J, Aitouche A, Veyron P, Touraine JL.

Transplantation. 2000 Apr 15;69(7):1452-7.

PMID:
10798770
7.

T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection.

Rolls HK, Kishimoto K, Dong VM, Illigens BM, Sho M, Sayegh MH, Benichou G, Fedoseyeva EV.

Transplantation. 2002 Oct 15;74(7):1053-7.

PMID:
12394855
8.

Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells.

Zhang Y, Kirken RA, Furian L, Janczewska S, Qu X, Hancock WW, Wang M, Tejpal N, Kerman R, Kahan BD, Stepkowski SM.

J Immunol. 2006 Jan 1;176(1):128-37.

9.

Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice.

Wasowska BA, Qian Z, Cangello DL, Behrens E, Van Tran K, Layton J, Sanfilippo F, Baldwin WM 3rd.

Transplantation. 2001 Mar 27;71(6):727-36.

PMID:
11330533
11.

Contribution of donor-specific antibodies to acute allograft rejection: evidence from B cell-deficient mice.

Brändle D, Joergensen J, Zenke G, Bürki K, Hof RP.

Transplantation. 1998 Jun 15;65(11):1489-93.

PMID:
9645808
12.

Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.

Wagnetz D, Sato M, Hirayama S, Matsuda Y, Juvet SC, Yeung JC, Guan Z, Zhang L, Liu M, Waddell TK, Keshavjee S.

Transplantation. 2012 Jun 27;93(12):1212-20. doi: 10.1097/TP.0b013e318250fbf5.

PMID:
23318304
13.

Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft.

Kwun J, Farris AB, Song H, Mahle WT, Burlingham WJ, Knechtle SJ.

Transplantation. 2015 Dec;99(12):2485-93. doi: 10.1097/TP.0000000000000805.

PMID:
26102611
14.

Asialo GM1 positive CD8+ T cells induce skin allograft rejection in the absence of the secondary lymphoid organs.

Yamanokuchi S, Ikai I, Nishitai R, Matsushita T, Sugimoto S, Shiotani T, Yamaoka Y.

J Surg Res. 2005 Nov;129(1):57-63. Epub 2005 Sep 2.

PMID:
16140338
15.

The composition of ectopic lymphoid structures suggests involvement of a local immune response in cardiac allograft vasculopathy.

Huibers MM, Gareau AJ, Vink A, Kruit R, Feringa H, Beerthuijzen JM, Siera-de Koning E, Peeters T, de Jonge N, de Weger RA, Lee TD.

J Heart Lung Transplant. 2015 May;34(5):734-45. doi: 10.1016/j.healun.2014.11.022. Epub 2014 Dec 8.

PMID:
25655346
16.

Interleukin-16 deficiency suppresses the development of chronic rejection in murine cardiac transplantation model.

Kimura N, Itoh S, Nakae S, Axtell RC, Velotta JB, Bos EJ, Merk DR, Gong Y, Okamura H, Nagamine CM, Adachi H, Kornfeld H, Robbins RC, Fischbein MP.

J Heart Lung Transplant. 2011 Dec;30(12):1409-17. doi: 10.1016/j.healun.2011.08.017.

PMID:
22055099
17.

Chronic rejection in H-2 matched cardiac allografts: early emergence of vasculopathy, alloantibody, and accumulation of IFN-gamma and IL-10 mRNA.

Zhang QW, Tomita Y, Matsuzaki G, Uchida T, Yoshikawa M, Nakashima Y, Sueishi K, Nomoto K, Yasui H.

Transpl Int. 2001 Jun;14(3):143-52.

18.

Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection.

Jiang H, Pan F, Erickson LM, Jang MS, Sanui T, Kunisaki Y, Sasazuki T, Kobayashi M, Fukui Y.

J Exp Med. 2005 Oct 17;202(8):1121-30.

19.

Preliminary findings in corneal allograft rejection in patients with keratoconus.

Hargrave S, Chu Y, Mendelblatt D, Mayhew E, Niederkorn J.

Am J Ophthalmol. 2003 Apr;135(4):452-60.

PMID:
12654360
20.

Effect of alloantibodies on corneal allograft survival.

Hegde S, Mellon JK, Hargrave SL, Niederkorn JY.

Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1012-8.

PMID:
11923241

Supplemental Content

Support Center